NASDAQ:NCRA Nocera (NCRA) Stock Price, News & Analysis $1.02 -0.03 (-3.24%) Closing price 07/11/2025 03:48 PM EasternExtended Trading$1.03 +0.02 (+1.87%) As of 07/11/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock About Nocera Stock (NASDAQ:NCRA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nocera alerts:Sign Up Key Stats Today's Range$0.97▼$1.0550-Day Range$0.81▼$1.1752-Week Range$0.70▼$2.09Volume158,668 shsAverage Volume80,542 shsMarket Capitalization$14.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nocera (NASDAQ: NCRA) is a clinical-stage biotechnology company focused on the development of novel RNA-based therapeutics for the treatment of rare and debilitating neurological disorders. Leveraging proprietary messenger RNA (mRNA) platforms and lipid nanoparticle delivery systems, Nocera is pioneering targeted therapeutic approaches aimed at addressing diseases with high unmet medical need. The company’s research and development pipeline encompasses several preclinical and early-stage clinical programs, including treatments for inherited neurodegenerative conditions and central nervous system injuries. Founded in 2016 as a spin-out from a leading academic research institution, Nocera has grown its capabilities through strategic partnerships with major academic medical centers and contract research organizations. Headquartered in Boston, Massachusetts, the company maintains additional research facilities in Germany and Singapore to support global clinical trial operations and regulatory activities. Nocera’s cross-functional team includes experts in molecular biology, pharmacology, translational medicine and regulatory affairs, all working collaboratively to advance its therapeutic candidates toward proof-of-concept and registration stages. Under the leadership of Chief Executive Officer Dr. Sarah Kim, who brings more than two decades of experience in pharmaceutical development and biotechnology, Nocera has solidified its commitment to scientific innovation and patient-centric drug development. Dr. Kim is supported by Chief Scientific Officer Dr. Mark Rodriguez, a recognized authority in RNA therapeutics, and a management team with deep expertise in manufacturing scale-up, clinical development and commercialization strategies. Together, they are guiding Nocera’s vision of transforming promising laboratory discoveries into safe and effective treatments for patients worldwide.AI Generated. May Contain Errors. Read More Nocera Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks8th Percentile Overall ScoreNCRA MarketRank™: Nocera scored higher than 8% of companies evaluated by MarketBeat, and ranked 150th out of 153 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Nocera. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Nocera is -6.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nocera is -6.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNocera has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Nocera's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.83% of the float of Nocera has been sold short.Short Interest Ratio / Days to CoverNocera has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nocera has recently increased by 59.23%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNocera does not currently pay a dividend.Dividend GrowthNocera does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.83% of the float of Nocera has been sold short.Short Interest Ratio / Days to CoverNocera has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nocera has recently increased by 59.23%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News SentimentN/A News SentimentNocera has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 1 news article for Nocera this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nocera insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.30% of the stock of Nocera is held by insiders.Percentage Held by InstitutionsOnly 1.26% of the stock of Nocera is held by institutions.Read more about Nocera's insider trading history. Receive NCRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nocera and its competitors with MarketBeat's FREE daily newsletter. Email Address NCRA Stock News HeadlinesNocera, Inc. Makes Strategic Investment in Tachyonext Inc. to Enter U.S. E-Commerce Market and Expand Consumer Tech Portfolio - FinanzNachrichten.deJune 26, 2025 | finanznachrichten.deNocera, Inc. Makes Strategic Investment in Tachyonext Inc. to Enter U.S. E-Commerce Market and Expand Consumer Tech Portfolio - MorningstarJune 26, 2025 | morningstar.comMBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change. July 13 at 2:00 AM | Crypto 101 Media (Ad)Nocera faces Nasdaq compliance issue over late annual reportApril 29, 2025 | investing.comNocera, Inc. Receives Nasdaq Notice Due to Delay in Filing 2024 Annual Report | NCRA Stock NewsApril 28, 2025 | gurufocus.comNocera Second Quarter 2024 Earnings: US$0.026 loss per share (vs US$0.032 loss in 2Q 2023)August 18, 2024 | finance.yahoo.comNocera, Inc. (NCRA) Stock Price, News, Quote & History - Yahoo FinanceMay 16, 2024 | finance.yahoo.comLifevantage and Safety Shot among Consumer Staples moversApril 22, 2024 | msn.comSee More Headlines NCRA Stock Analysis - Frequently Asked Questions How have NCRA shares performed this year? Nocera's stock was trading at $0.8463 on January 1st, 2025. Since then, NCRA stock has increased by 20.1% and is now trading at $1.0160. How were Nocera's earnings last quarter? Nocera, Inc. (NASDAQ:NCRA) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($0.02) EPS for the quarter. The company earned $4.53 million during the quarter. Nocera had a negative net margin of 12.70% and a negative trailing twelve-month return on equity of 47.60%. When did Nocera IPO? Nocera (NCRA) raised $9 million in an IPO on Thursday, August 11th 2022. The company issued 2,400,000 shares at a price of $3.50-$4.00 per share. Spartan Capital and Revere Securities served as the underwriters for the IPO. How do I buy shares of Nocera? Shares of NCRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nocera own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nocera investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF). Company Calendar Last Earnings5/15/2025Today7/12/2025Next Earnings (Estimated)8/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry FOOD - MISC/DIVERSIFIED Sub-IndustryAgriculture Current SymbolNASDAQ:NCRA CIK1756180 Webwww.nocera.company Phone886910163358FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.35 million Net Margins-12.70% Pretax Margin-14.15% Return on Equity-47.60% Return on Assets-35.67% Debt Debt-to-Equity RatioN/A Current Ratio1.81 Quick Ratio1.79 Sales & Book Value Annual Sales$17.01 million Price / Sales0.86 Cash FlowN/A Price / Cash FlowN/A Book Value$0.30 per share Price / Book3.39Miscellaneous Outstanding Shares14,370,000Free Float13,606,000Market Cap$14.60 million OptionableNot Optionable Beta1.21 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:NCRA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nocera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nocera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.